Anteris Technologies Global Corp. Common Stock (AVR) - Total Assets
Based on the latest financial reports, Anteris Technologies Global Corp. Common Stock (AVR) holds total assets worth $272.51 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Anteris Technologies Global Corp. Common Stock - Total Assets Trend (2020–2025)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's total assets have evolved over time, based on quarterly financial data. Also see AVR market cap overview for the company's overall valuation and market capitalisation.
Anteris Technologies Global Corp. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2025)
Anteris Technologies Global Corp. Common Stock's total assets of $272.51 Million consist of 68.2% current assets and 31.8% non-current assets. Review Anteris Technologies Global Corp. Common total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 54.7% |
| Accounts Receivable | $32.00K | 0.1% |
| Inventory | $735.00K | 3.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $65.00K | 0.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how Anteris Technologies Global Corp. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See AVR stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Anteris Technologies Global Corp. Common Stock's current assets represent 68.2% of total assets in 2025, an increase from 64.0% in 2020.
- Cash Position: Cash and equivalents constituted 54.7% of total assets in 2025, up from 34.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 11.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 3.2% of total assets.
Anteris Technologies Global Corp. Common Stock Competitors by Total Assets
Key competitors of Anteris Technologies Global Corp. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.66 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.02 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
|
T&L Co. Ltd
KQ:340570
|
Korea | ₩219.17 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Anteris Technologies Global Corp. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 14.20 | 2.41 | 2.98 |
| Quick Ratio | 14.20 | 2.38 | 2.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $242.29 Million | $18.87 Million | $11.21 Million |
Anteris Technologies Global Corp. Common Stock - Advanced Valuation Insights
This section examines the relationship between Anteris Technologies Global Corp. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.50 |
| Latest Market Cap to Assets Ratio | 32.59 |
| Asset Growth Rate (YoY) | -71.5% |
| Total Assets | $23.00 Million |
| Market Capitalization | $749.46 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Anteris Technologies Global Corp. Common Stock's assets at a significant premium (32.59x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Anteris Technologies Global Corp. Common Stock's assets decreased by 71.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Anteris Technologies Global Corp. Common Stock (2020–2025)
The table below shows the annual total assets of Anteris Technologies Global Corp. Common Stock from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $23.00 Million | -71.50% |
| 2024-12-31 | $80.70 Million | +164.35% |
| 2023-12-31 | $30.53 Million | +90.97% |
| 2022-12-31 | $15.99 Million | -25.42% |
| 2021-12-31 | $21.43 Million | +119.74% |
| 2020-12-31 | $9.75 Million | -- |
About Anteris Technologies Global Corp. Common Stock
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT ant… Read more